Evidence map›Paper›PMID 31694704›Full record

ArticleBMC complementary and alternative medicine2019

Isolation of bioactive compounds from Bergenia ciliata (haw.) Sternb rhizome and their antioxidant and anticholinesterase activities.

Roheena Zafar, Habib Ullah, Muhammad Zahoor, Abdul Sadiq

Abstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Protective role ofFrontiers in pharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Evaluation ofFrontiers in chemistry · 2024
    Article
  9. Article
  10. Article
  11. Antioxidant and Anti-Aging Phytoconstituents fromMolecules (Basel, Switzerland) · 2023
    Article
  12. Review
  13. Life (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Chemistry and Bioactivity ofMolecules (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Roheena ZafarDepartment of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Pakistan.
Habib UllahDepartment of Chemistry, University of Malakand, Chakdara, Dir Lower, KPK, 18800, Pakistan.
Muhammad ZahoorDepartment of Chemistry, University of Malakand, Chakdara, Dir Lower, KPK, 18800, Pakistan. mohammadzahoorus@yahoo.com.ORCID http://orcid.org/0000-0002-4528-8517
Abdul SadiqDepartment of Pharmacy, University of Malakand, Chakdara, Dir Lower, KPK, 18800, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBergenia ciliata is a medicinal plant used for the treatment of diarrhea, vomiting, fever, cough, diabetes, cancer, pulmonary disorders and wound healing.

methodsIn this study, Bergenia ciliata crude extract, subfractions, and isolated compounds were evaluated for their antioxidant and anticholinesterase potential. The free radical scavenging capacities of the extracts determined using DPPH and ABTS assays. The anticholinesterase potentials were determined using acetylcholine esterase and butyryl choline esterase enzymes. To determine the phytochemical composition, the extracts were subjected to HPLC analysis and silica gel column isolation. Based on HPLC fingerprinting results, the ethyl acetate fraction was found to have more bioactive compounds and was therefore subjected to silica gel column isolation. As a result, three compounds; pyrogallol, rutin, and morin were isolated in the pure state. The structures of the isolated compounds were elucidated using spectroscopic techniques like

resultsThe crude extract showed maximum anticholinesterase (acetylcholinesterase = 90.22 ± 1.15% and butyrylcholinesterase = 88.22 ± 0.71%) and free radical scavenging (87.37 ± 2.45 and 83.50 ± 0.70% respectively against DPPH and ABTS radicals) potentials. The total phenolic contents (expressed as equivalent of gallic acid; mgGAE/g) were higher in ethyl acetate fraction (80.96 ± 1.74) followed by crude extract (70.65 ± 0.86) while the flavonoid contents (expressed as quercetin equivalent; mgQE/g) and were higher in crude extract (88.40 ± 1.12) followed by n-butanol fraction (60.10 ± 1.86). The isolated bioactive compounds pyrogallol, rutin, and morin were found active against ABTS and DPPH free radicals. Amongst them, pyrogallol was more active against both free radicals. Reasonable anticholinesterase activities were recorded for pyrogallol against selected enzymes.

conclusionThe extracts and isolated compounds showed antioxidant and acetylcholinesterase inhibitory potentials. It was concluded that this plant could be helpful in the treatment of oxidative stress and neurological disorders if used in the form of extracts.

Indexed as

AcetylcholinesteraseAntioxidantsButyrylcholinesteraseCholinesterase InhibitorsFlavonoidsPhenolsPlant ExtractsRhizomeSaxifragaceaeAcetylcholinesteraseAntioxidantsButyrylcholinesteraseCholinesterase InhibitorsFlavonoidsPhenolsPlant ExtractsAnticholinesterase assayAntioxidantsBergenia ciliata rhizomeMorinPyrogallolRutinTotal flavonoid contentsTotal phenolic contents

Identifiers

PMID31694704
PMCPMC6833214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.